S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
NASDAQ:SAGE

Sage Therapeutics (SAGE) News Today

$59.54
+2.84 (+5.01%)
(As of 06/9/2023 ET)
Compare
Today's Range
$56.46
▼
$59.68
50-Day Range
$40.65
▼
$59.54
52-Week Range
$30.67
▼
$59.68
Volume
1.00 million shs
Average Volume
407,608 shs
Market Capitalization
$3.56 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$51.54
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability
Get Sage Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SAGE and its competitors with MarketBeat's FREE daily newsletter.



SAGE Media Mentions By Week

SAGE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SAGE
News Sentiment
▼
1.02

0.90
▲
Average
Medical
News Sentiment

SAGE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SAGE Articles
This Week
▼
6

4
▲
SAGE Articles
Average Week

SourceHeadline
markets.businessinsider.com logoRBC Capital Sticks to Their Buy Rating for SAGE Therapeutics (SAGE)
markets.businessinsider.com - June 10 at 1:18 AM
marketbeat.com logoJPMorgan Chase & Co. Has $53.88 Million Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE)
marketbeat.com - June 9 at 5:36 AM
finance.yahoo.com logoSage Therapeutics to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
finance.yahoo.com - June 5 at 10:12 AM
marketbeat.com logoVictory Capital Management Inc. Sells 12,636 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE)
marketbeat.com - June 5 at 5:28 AM
marketbeat.com logoSage Therapeutics, Inc. (NASDAQ:SAGE) Shares Bought by Capital Fund Management S.A.
marketbeat.com - June 4 at 7:38 AM
marketbeat.com logoHRT Financial LP Has $783,000 Stake in Sage Therapeutics, Inc. (NASDAQ:SAGE)
marketbeat.com - June 2 at 6:25 AM
marketbeat.com logoFinepoint Capital LP Sells 47,548 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE)
marketbeat.com - May 31 at 2:06 PM
finance.yahoo.com logo15 Most Suicidal States in America
finance.yahoo.com - May 31 at 10:24 AM
marketbeat.com logoDimensional Fund Advisors LP Purchases 242,969 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE)
marketbeat.com - May 29 at 5:25 AM
MarketBeat logoAnalysts Set Sage Therapeutics, Inc. (NASDAQ:SAGE) Price Target at $52.83
americanbankingnews.com - May 26 at 2:16 AM
MarketBeat logoSage Therapeutics (NASDAQ:SAGE) PT Raised to $61.00
americanbankingnews.com - May 25 at 3:24 AM
msn.com logoB of A Securities Maintains Sage Therapeutics (SAGE) Buy Recommendation
msn.com - May 23 at 11:49 PM
marketbeat.com logoSage Therapeutics, Inc. (NASDAQ:SAGE) Shares Bought by Thrivent Financial for Lutherans
marketbeat.com - May 23 at 4:51 AM
marketbeat.com logoSage Therapeutics, Inc. (NASDAQ:SAGE) Given Consensus Recommendation of "Hold" by Analysts
marketbeat.com - May 23 at 2:50 AM
markets.businessinsider.com logoSAGE Therapeutics (SAGE) Receives a Buy from Bank of America Securities
markets.businessinsider.com - May 23 at 1:08 AM
MarketBeat logoSage Therapeutics (NASDAQ:SAGE) Coverage Initiated at StockNews.com
americanbankingnews.com - May 22 at 8:32 AM
marketbeat.com logoCambridge Investment Research Advisors Inc. Purchases Shares of 36,431 Sage Therapeutics, Inc. (NASDAQ:SAGE)
marketbeat.com - May 19 at 5:27 AM
finance.yahoo.com logoElizabeth Barrett At Sage Therapeutics Tops Up Holding By US$51k \
finance.yahoo.com - May 18 at 8:02 AM
marketbeat.com logoSage Therapeutics (NASDAQ:SAGE) Research Coverage Started at StockNews.com
marketbeat.com - May 18 at 3:52 AM
markets.businessinsider.com logoBank of America Securities Sticks to Their Buy Rating for Sarepta Therapeutics (SRPT)
markets.businessinsider.com - May 15 at 9:22 AM
MarketBeat logoElizabeth Barrett Acquires 1,000 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) Stock
americanbankingnews.com - May 14 at 7:00 AM
msn.com logoMorgan Stanley Maintains Sage Therapeutics (SAGE) Equal-Weight Recommendation
msn.com - May 11 at 5:10 PM
MarketBeat logoSage Therapeutics (NASDAQ:SAGE) Upgraded to "Hold" at StockNews.com
americanbankingnews.com - May 11 at 6:00 AM
marketbeat.com logoSage Therapeutics (NASDAQ:SAGE) Raised to "Hold" at StockNews.com
marketbeat.com - May 10 at 1:33 AM
msn.com logoSage Therapeutics: Mid-2023 Data Readout And Possible FDA Approval Make This A Must Watch
msn.com - May 9 at 9:18 AM
marketbeat.com logoTD Asset Management Inc Cuts Position in Sage Therapeutics, Inc. (NASDAQ:SAGE)
marketbeat.com - May 9 at 5:25 AM
MarketBeat logoFinancial Analysis: Sage Therapeutics (NASDAQ:SAGE) versus Mereo BioPharma Group (NASDAQ:MREO)
americanbankingnews.com - May 9 at 3:22 AM
MarketBeat logoWedbush Equities Analysts Increase Earnings Estimates for Sage Therapeutics, Inc. (NASDAQ:SAGE)
americanbankingnews.com - May 7 at 1:40 AM
MarketBeat logoAnalysts Offer Predictions for Sage Therapeutics, Inc.'s Q2 2023 Earnings (NASDAQ:SAGE)
americanbankingnews.com - May 7 at 1:40 AM
MarketBeat logoRoyal Bank of Canada Increases Sage Therapeutics (NASDAQ:SAGE) Price Target to $63.00
americanbankingnews.com - May 6 at 6:34 AM
MarketBeat logoFY2026 EPS Estimates for Sage Therapeutics, Inc. (NASDAQ:SAGE) Reduced by HC Wainwright
americanbankingnews.com - May 6 at 5:14 AM
MarketBeat logoHC Wainwright Equities Analysts Decrease Earnings Estimates for Sage Therapeutics, Inc. (NASDAQ:SAGE)
americanbankingnews.com - May 6 at 5:14 AM
MarketBeat logoSage Therapeutics, Inc. Expected to Post Q2 2023 Earnings of ($2.55) Per Share (NASDAQ:SAGE)
americanbankingnews.com - May 5 at 6:50 AM
MarketBeat logoSage Therapeutics, Inc. Forecasted to Earn Q2 2023 Earnings of ($2.54) Per Share (NASDAQ:SAGE)
americanbankingnews.com - May 5 at 6:50 AM
marketbeat.com logoHC Wainwright Weighs in on Sage Therapeutics, Inc.'s Q2 2023 Earnings (NASDAQ:SAGE)
marketbeat.com - May 5 at 6:46 AM
MarketBeat logoSage Therapeutics (NASDAQ:SAGE) Rating Increased to Hold at StockNews.com
americanbankingnews.com - May 5 at 2:56 AM
MarketBeat logoSage Therapeutics (NASDAQ:SAGE) Lifted to Hold at StockNews.com
americanbankingnews.com - May 4 at 4:00 AM
msn.com logoCitigroup Maintains Sage Therapeutics (SAGE) Neutral Recommendation
msn.com - May 3 at 8:05 PM
msn.com logoRBC Capital Maintains Sage Therapeutics (SAGE) Outperform Recommendation
msn.com - May 3 at 8:05 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: SAGE Therapeutics (SAGE) and ChitogenX (OtherCHNXF)
markets.businessinsider.com - May 3 at 3:05 PM
msn.com logoHC Wainwright & Co. Reiterates Sage Therapeutics (SAGE) Neutral Recommendation
msn.com - May 3 at 3:05 PM
markets.businessinsider.com logoSAGE Therapeutics (SAGE) Receives a Hold from H.C. Wainwright
markets.businessinsider.com - May 3 at 10:04 AM
MarketBeat logoBrokerages Set Sage Therapeutics, Inc. (NASDAQ:SAGE) Price Target at $52.58
americanbankingnews.com - May 3 at 4:02 AM
msn.com logoSage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates
msn.com - May 2 at 9:42 AM
finance.yahoo.com logoSage Therapeutics Announces First Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
finance.yahoo.com - May 2 at 9:42 AM
seekingalpha.com logoSage Therapeutics Q1 2023 Earnings Preview
seekingalpha.com - May 1 at 5:17 PM
msn.com logoSage Therapeutics's Earnings Outlook
msn.com - May 1 at 12:17 PM
marketwatch.com logoPostpartum Depression Therapeutics Market Top Key Players by 2031
marketwatch.com - April 28 at 8:11 AM
marketbeat.com logoSage Therapeutics, Inc. (NASDAQ:SAGE) Receives Average Recommendation of "Hold" from Brokerages
marketbeat.com - April 28 at 2:55 AM
fortune.com logoDual COVID and mental health pandemics are wreaking havoc on Americans. When it comes to the latter, ‘the worst may still be to come’
fortune.com - April 26 at 9:08 PM
Get Sage Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SAGE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:SAGE) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -